Endologix has appointed John Onopchenko as the company’s chief operating officer, effective as of 30 October, 2017. Onopchenko will be responsible for managing Endologix’s manufacturing, supply chain, and quality organisations.
A press release explains that Onopchenko brings almost thirty years of executive leadership experience in medical devices to Endologix. Most recently, he was executive vice president for Acutus Medical, where he was responsible for programme management/product development, quality, marketing, and sales. Prior to that, he served on the board of directors of Volcano and later became the company’s executive vice president /chief operating officer. While at Volcano, he was responsible for its peripheral business unit, regulatory affairs, quality assurance, programme management/product development, clinical affairs, business development, and the Axsun business unit.
Following Volcano’s acquisition by Philips, John was retained as senior vice president and head of therapy strategy. Before joining Volcano, Onopchenko spent 10 years at Johnson & Johnson, where he led medical device investments with Johnson & Johnson Development Corporation and was responsible for worldwide operations for advanced sterilisation products.
John McDermott, chief executive officer for Endologix, said, “We are very excited to welcome John to Endologix’s executive team. His impressive and versatile leadership expertise will be invaluable in helping us revolutionise aortic care for life and build on our position as an innovative leader in the endovascular aortic market.”
Onopchenko said, “I am thrilled to join Endologix in this role. The company’s dedication to aortic care, coupled with its breadth of products, uniquely positions Endologix to create great value for physicians and patients. I look forward to being a part of the leadership team.”
